Association of aromatase and estrogen receptor gene polymorphisms with hip fractures

Osteoporosis International

Volumn 19, Issue 6, 2008, Pages 787-792

  Valero, C ^a   Perez Castrillon J L ^b   Zarrabeitia, M T ^a   Hernandez J L ^a   Alonso, M A ^a   Del Pino Montes, J ^c   Olmos, J M ^a   Gonzalez Macias J ^a   Riancho, J A ^a  

^a UNIVERSITY OF CANTABRIA   (Spain)

^b UNIVERSITY OF VALLADOLID   (Spain)

^c UNIVERSITY OF SALAMANCA   (Spain)

Author keywords

Aromatase; Estrogen receptor; Hip fractures; Osteoporosis; Polymorphisms

Indexed keywords

AROMATASE; ESTROGEN RECEPTOR ALPHA; RNA;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC VARIABILITY; GENOTYPE; HIP FRACTURE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AGED; AGED, 80 AND OVER; AROMATASE; ESTROGEN RECEPTOR ALPHA; FEMALE; FEMUR NECK; GENE EXPRESSION; GENOTYPE; HIP FRACTURES; HUMANS; MIDDLE AGED; POLYMORPHISM, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 43249085938     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-007-0491-0     Document Type: Article

References (31)

1. Ralston SH, de Crombrugghe B (2006) Genetic regulation of bone mass and susceptibility to osteoporosis. Genes Dev 20:2492-2506
2. Baldock PA, Eisman JA (2004) Genetic determinants of bone mass. Curr Opin Rheumatol 16:450-456
3. Peacock M, Turner CH, Econs MJ, Foroud T (2002) Genetics of osteoporosis. Endocr Rev 23:303-326
4. Riggs BL, Khosla S, Melton LJ III (2002) Sex steroids and the construction and conservation of adult skeleton. Endocr Rev 23:279-302
5. Syed FS, Khosla S (2005) Mechanisms of sex steroid effects on bone. Biochem Biophys Res Commun 328:688-696
6. Simpson ER (2000) Role of aromatase in sex steroid action. J Mol Endocrinol 25:1549-1556
7. McCloskey E (2006) Effects of third-generation aromatase inhibitors on bone. Eur J Cancer 42:1044-1051
8. Masi L, Becherini L, Gennari L et al (2001) Polymorphism of the aromatase gene in postmenopausal Italian women: distribution and correlation with bone mass and fracture risk. J Clin Endocrinol Metab 86:2263-2269
9. Somner J, McLellan S, Cheung J et al (2004) Polymorphisms in the P450 c17(17-hydroxylase/17,20-lyase) and P450 c19 (aromatase) genes: association with serum sex steroid concentrations and bone mineral density in postmenopausal women. J Clin Endocrinol Metab 89:344-351
10. Zarrabeitia MT, Hernandez JL, Valero C et al (2004) A common polymorphism in the 5′-untranslated region of the aromatase gene influences bone mass and fracture risk. Eur J Endocrinol 150:699-704
11. Riancho JA, Zarrabeitia MT, Valero C, Sanudo C, Mijares V, Gonzalez-Macias J (2006) A gene-to-gene interaction between aromatase and estrogen receptors influences bone mineral density. Eur J Endocrinol 155:53-59
12. Riancho JA, Zarrabeitia MT, Valero C et al (2005) Aromatase gene and osteoporosis: relationship of ten polymorphic loci with bone mineral density. Bone 36:917-925
13. Choi JY, Shin A, Park SK et al (2005) Genetic polymorphisms of OPG, RANK, and ESR1 and bone mineral density in Korean postmenopausal women. Calcif Tissue Int 77:152-159
14. Gennari L, Merlotti D, De Paola V et al (2005) Estrogen receptor gene polymorphisms and the genetics of osteoporosis: a HuGE review. Am J Epidemiol 161:307-320
15. Kobayashi N, Fujino T, Shirogane T et al (2002) Estrogen receptor alpha polymorphism as a genetic marker for bone loss, vertebral fractures and susceptibility to estrogen. Maturitas 41:193-201
16. Nam HS, Shin MH, Kweon SS et al (2005) Association of estrogen receptor-alpha gene polymorphisms with bone mineral density in postmenopausal Korean women. J Bone Miner Metab 23:84-89
17. Kjaergaard AD, Ellervik C, Tybjaerg-Hansen A (2007) Estrogen receptor alpha polymorphism and risk of cardiovascular disease, cancer, and hip fracture: cross-sectional, cohort, and case-control studies and a meta-analysis. Circulation 115:861-871
18. Aerssens J, Dequeker J, Peeters J, Breemans S, Broos P, Boonen S (2000) Polymorphisms of the VDR, ER and COLIA1 genes and osteoporotic hip fracture in elderly postmenopausal women. Osteoporos Int 11:583-591
19. Ioannidis JPA, Ralston SH, Bennett ST, Brandi ML, Grinberg D, Karassa FB et al (2004) Differential genetics effects of ESR1 gene polymorphisms on osteoporosis outcomes. JAMA 292:2105-2114
20. Ioannidis JPA, Stavrou I, Trikalinos TA et al (2002) Association of polymorphisms of the estrogen receptor alpha gene with bone mineral density and fracture risk in women: a meta-analysis. J Bone Miner Res 17:2048-2060
21. Riancho JA, Valero C, Naranjo A, Morales DJ, Sanudo C, Zarrabeitia MT (2007) Identification of an aromatase haplotype that is associated with gene expression and postmenopausal osteoporosis. J Clin Endocrinol Metab 92:660-665
22. Haiman CA, Dossus L, Setiawan VW et al (2007) Genetic variation at the CYP19A1 locus predicts circulating estrogen levels but not breast cancer risk in postmenopausal women. Cancer Res 67:1893-1897
23. Olson SH, Bandera EV, Orlow I (2007) Variants in estrogen biosynthesis genes, sex steroid hormone levels, and endometrial cancer: a HuGE review. Am J Epidemiol 165:235-245
24. Dick IM, Devine A, Prince RL (2005) Association of an aromatase TTTA repeat polymorphism with circulating estrogen, bone structure, and biochemistry in older women. Am J Physiol Endocrinol Metab 288:E989-E995
25. Xiong DH, Zhao LJ, Xiao P et al (2006) Robust and comprehensive analysis of 20 osteoporosis candidate genes by very high-density single-nucleotide polymorphism screen among 405 white nuclear families identified significant association and gene-gene interaction. J Bone Miner Res 21:1678-1695
26. Riancho JA (2007) Polymorphisms in the CYP19 gene that influence bone mineral density. Pharmacogenomics 8:339-352
27. Herrington DM, Howard TD, Brosnihan KB et al (2002) Common estrogen receptor polymorphism augments effects of hormone replacement therapy on E-selectin but not C-reactive protein. Circulation 105:1879-1882
28. Acha O, Hernandez JL, Penado S, Cano M, Riancho JA (2003) Factores de riesgo de ictus en pacientes de diferentes edades. Rev Clin Esp 203:189-192
29. Cummings SR, Nevitt MC, Browner WS et al (1995) Risk factors for hip fracture in white women. N Engl J Med 332:767-773
30. Kanis JA, Johansson H, Oden A et al (2004) A family history of fracture and fracture risk: a meta-analysis. Bone 35:1029-1037
31. Michaelsson K, Melhus H, Ferm H, Ahlbom A, Pedersen NL (2005) Genetic liability to fractures in the elderly. Arch Intern Med 165:1825-1830